IR@PKUHSC  > 北京大学临床肿瘤学院
学科主题临床医学
Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome
Wang, L.; Peng, L.; Dong, B.; Kong, L.; Meng, L.; Yan, L.; Xie, Y.; Shou, C.
关键词breast cancer PRL-3 prognosis
刊名ANNALS OF ONCOLOGY
2006-10-01
DOI10.1093/annonc/mdl159
17期:10页:1517-1522
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology
研究领域[WOS]Oncology
关键词[WOS]TYROSINE-PHOSPHATASE ; COLORECTAL-CANCER ; PRL-3 PHOSPHATASE ; CYCLIN-E ; METASTASIS ; EXPRESSION ; PROTEIN ; MOTILITY ; CELLS ; INVASION
英文摘要

Background: Increasing evidence has suggested that phosphatase of regenerating liver-3 (PRL-3) plays an important role in cancer cell migration, invasion and metastasis. However, the correlation between the PRL-3 expression and clinical outcome in breast cancer has not been investigated.

Patients and methods: Using a PRL-3-specific monoclonal antibody 3B6, PRL-3 expression was assessed by immunohistochemistry in tumor tissues from 382 breast cancer patients with a median follow-up of 65 months.

Results: We found that 34.8% patients expressed a high level of PRL-3 protein in their tumors. Patients with a high level of PRL-3 in the tumor had a worse disease-specific survival (DSS) rate than those with a low level of PRL-3 (74.0% versus 84.9%, P = 0.011), and PRL-3 remained an independent prognostic marker for DSS (HR 1.8, 95% CI 1.1-2.9, P = 0.019) in multivariate analysis. More importantly, in 219 node-negative patients, PRL-3 showed a significant correlation with DSS in univariate analysis (P = 0.014) and retained a borderline significance (HR 2.65, 95% CI 0.92-7.64, P = 0.071) in multivariate analysis.

Conclusions: Our results suggest that PRL-3 may serve as an unfavorable prognostic marker in breast cancer, especially for patients with node-negative diseases. Thus, our findings may provide useful information for individualized therapy in the clinical setting.

语种英语
WOS记录号WOS:000240926200007
引用统计
被引频次:51[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/67610
专题北京大学临床肿瘤学院
作者单位1.People Hosp Henan Prov, Zhengzhou, HeNan, Peoples R China
2.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Dept Biochem & Mol Biol, Beijing 100036, Peoples R China
3.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Dept Pathol, Beijing 100036, Peoples R China
4.Peking Univ, Sch Oncol, Beijing Canc Hosp & Inst, Breast Ctr, Beijing 100036, Peoples R China
推荐引用方式
GB/T 7714
Wang, L.,Peng, L.,Dong, B.,et al. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome[J]. ANNALS OF ONCOLOGY,2006,17(10):1517-1522.
APA Wang, L..,Peng, L..,Dong, B..,Kong, L..,Meng, L..,...&Shou, C..(2006).Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome.ANNALS OF ONCOLOGY,17(10),1517-1522.
MLA Wang, L.,et al."Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome".ANNALS OF ONCOLOGY 17.10(2006):1517-1522.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Wang, L.]的文章
[Peng, L.]的文章
[Dong, B.]的文章
百度学术
百度学术中相似的文章
[Wang, L.]的文章
[Peng, L.]的文章
[Dong, B.]的文章
必应学术
必应学术中相似的文章
[Wang, L.]的文章
[Peng, L.]的文章
[Dong, B.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。